First Time Loading...

Exscientia PLC
NASDAQ:EXAI

Watchlist Manager
Exscientia PLC Logo
Exscientia PLC
NASDAQ:EXAI
Watchlist
Price: 3.95 USD -4.36% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

EXAI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Exscientia Plc operates as an AI-driven pharmatech company which is engaged in designing and developing patient-based drugs. [ Read More ]

The intrinsic value of one EXAI stock under the Base Case scenario is 2.45 USD. Compared to the current market price of 3.95 USD, Exscientia PLC is Overvalued by 38%.

Key Points:
EXAI Intrinsic Value
Base Case
2.45 USD
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Exscientia PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling EXAI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Exscientia PLC

Provide an overview of the primary business activities
of Exscientia PLC.

What unique competitive advantages
does Exscientia PLC hold over its rivals?

What risks and challenges
does Exscientia PLC face in the near future?

Summarize the latest earnings call
of Exscientia PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Exscientia PLC.

Provide P/S
for Exscientia PLC.

Provide P/E
for Exscientia PLC.

Provide P/OCF
for Exscientia PLC.

Provide P/FCFE
for Exscientia PLC.

Provide P/B
for Exscientia PLC.

Provide EV/S
for Exscientia PLC.

Provide EV/GP
for Exscientia PLC.

Provide EV/EBITDA
for Exscientia PLC.

Provide EV/EBIT
for Exscientia PLC.

Provide EV/OCF
for Exscientia PLC.

Provide EV/FCFF
for Exscientia PLC.

Provide EV/IC
for Exscientia PLC.

Show me price targets
for Exscientia PLC made by professional analysts.

What are the Revenue projections
for Exscientia PLC?

How accurate were the past Revenue estimates
for Exscientia PLC?

What are the Net Income projections
for Exscientia PLC?

How accurate were the past Net Income estimates
for Exscientia PLC?

What are the EPS projections
for Exscientia PLC?

How accurate were the past EPS estimates
for Exscientia PLC?

What are the EBIT projections
for Exscientia PLC?

How accurate were the past EBIT estimates
for Exscientia PLC?

Compare the revenue forecasts
for Exscientia PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Exscientia PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Exscientia PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Exscientia PLC compared to its peers.

Compare the P/E ratios
of Exscientia PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Exscientia PLC with its peers.

Analyze the financial leverage
of Exscientia PLC compared to its main competitors.

Show all profitability ratios
for Exscientia PLC.

Provide ROE
for Exscientia PLC.

Provide ROA
for Exscientia PLC.

Provide ROIC
for Exscientia PLC.

Provide ROCE
for Exscientia PLC.

Provide Gross Margin
for Exscientia PLC.

Provide Operating Margin
for Exscientia PLC.

Provide Net Margin
for Exscientia PLC.

Provide FCF Margin
for Exscientia PLC.

Show all solvency ratios
for Exscientia PLC.

Provide D/E Ratio
for Exscientia PLC.

Provide D/A Ratio
for Exscientia PLC.

Provide Interest Coverage Ratio
for Exscientia PLC.

Provide Altman Z-Score Ratio
for Exscientia PLC.

Provide Quick Ratio
for Exscientia PLC.

Provide Current Ratio
for Exscientia PLC.

Provide Cash Ratio
for Exscientia PLC.

What is the historical Revenue growth
over the last 5 years for Exscientia PLC?

What is the historical Net Income growth
over the last 5 years for Exscientia PLC?

What is the current Free Cash Flow
of Exscientia PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Exscientia PLC.

Financials

Balance Sheet Decomposition
Exscientia PLC

Current Assets 404.9m
Cash & Short-Term Investments 361.2m
Receivables 35.9m
Other Current Assets 7.9m
Non-Current Assets 105.8m
Long-Term Investments 3m
PP&E 67.5m
Intangibles 34.6m
Other Non-Current Assets 663k
Current Liabilities 65.1m
Accounts Payable 11.3m
Accrued Liabilities 22.2m
Other Current Liabilities 31.5m
Non-Current Liabilities 89.9m
Long-Term Debt 16.5m
Other Non-Current Liabilities 73.4m
Efficiency

Earnings Waterfall
Exscientia PLC

Revenue
20.1m GBP
Cost of Revenue
-27.4m GBP
Gross Profit
-7.3m GBP
Operating Expenses
-167.1m GBP
Operating Income
-174.5m GBP
Other Expenses
28.5m GBP
Net Income
-146m GBP

Free Cash Flow Analysis
Exscientia PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

EXAI Profitability Score
Profitability Due Diligence

Exscientia PLC's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
14/100
Profitability
Score

Exscientia PLC's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

EXAI Solvency Score
Solvency Due Diligence

Exscientia PLC's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
61/100
Solvency
Score

Exscientia PLC's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EXAI Price Targets Summary
Exscientia PLC

Wall Street analysts forecast EXAI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXAI is 8.84 USD with a low forecast of 7.07 USD and a high forecast of 10.5 USD.

Lowest
Price Target
7.07 USD
79% Upside
Average
Price Target
8.84 USD
124% Upside
Highest
Price Target
10.5 USD
166% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

EXAI Price
Exscientia PLC

1M 1M
-34%
6M 6M
-24%
1Y 1Y
-23%
3Y 3Y
-85%
5Y 5Y
-85%
10Y 10Y
-85%
Annual Price Range
3.95
52w Low
3.95
52w High
8.9
Price Metrics
Average Annual Return -48.72%
Standard Deviation of Annual Returns 33.46%
Max Drawdown -85%
Shares Statistics
Market Capitalization 496.5m USD
Shares Outstanding 126 120 000
Percentage of Shares Shorted 7.18%

EXAI Return Decomposition
Main factors of price return

What is price return decomposition?

EXAI News

Last Important Events
Exscientia PLC

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Exscientia PLC

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Exscientia PLC Logo
Exscientia PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

496.5m USD

Dividend Yield

0%

Description

Exscientia Plc operates as an AI-driven pharmatech company which is engaged in designing and developing patient-based drugs. The company is headquartered in Oxford, Oxfordshire and currently employs 208 full-time employees. The company went IPO on 2021-10-01. The firm's focus is on the discovery, design and development of small molecule drug candidates. The firm has built a complete end-to-end solution of artificial intelligence (AI), and experimental technologies for target identification, drug candidate design, translational models and patient selection. Its AI process is comprised of the four elements: Precision Target, Precision Design, Precision Experiment and Precision Medicine. Its AI-design includes a range of deep learning and machine learning algorithms, generative methods, active learning and natural language processing. These methods are used to guide target selection, to design the precise molecular architecture of potential drug molecules and to analyze patient tissues to prioritize the molecules. The firm's lead drug candidate, EXS21546, is in early stage of development.

Contact

OXFORDSHIRE
Oxford
The Schrodinger Building, Oxford Science Park
+441865818941.0
https://www.exscientia.ai/

IPO

2021-10-01

Employees

208

Officers

Chief Scientific Officer, Interim CEO, Principal Executive Officer & Executive Director
Dr. David Hallett Ph.D.
CFO, Chief Strategy Officer & Executive Director
Mr. Ben R. Taylor
Chief Medical Officer
Dr. Michael Krams M.D.
Chief Information Officer
Ms. Eileen Jennings-Brown
Vice President of Investor Relations
Ms. Sara Sherman
Vice President of Legal & Company Secretary
Mr. Dan Ireland
Show More
Executive Vice President of Corporate Development
Mr. Parker Moss
Chief People Officer
Ms. Caroline Rowland
Chief Business Officer
Mr. Richard Law
Chief Data Officer
Dr. John P. Overington Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one EXAI stock?

The intrinsic value of one EXAI stock under the Base Case scenario is 2.45 USD.

Is EXAI stock undervalued or overvalued?

Compared to the current market price of 3.95 USD, Exscientia PLC is Overvalued by 38%.